NUDCD1 and neoplasm: This lesser known gene was first described in the context as a tumour antigen (also known as Chronic Myelogenous Leukemia Tumour Antigen 66 [CML66]), although it has been perceived as being an immunogenic epitope capable of evoking host immune response (40, 41).